In this Review:
International guidelines for use of eplerenone in heart failure
Unmet needs in the management of heart failure in Australia
Eplerenone indications and reimbursement information
Clinical trials of eplerenone in heart failure
• Post-MI (EPHESUS)
• NYHA Class II (EMPHASIS-HF)
Identification of patients suitable for eplerenone
Management of eplerenone
Independent commentary by Associate Professor John Amerena, FRACP, FACC, FCSANZ, Dept. of Clinical and Biomedical Science, University of Melbourne (Geelong).
Please login below to download this issue (PDF)